These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 9143092)
21. Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Wolf CJ; Hotchkiss A; Ostby JS; LeBlanc GA; Gray LE Toxicol Sci; 2002 Jan; 65(1):71-86. PubMed ID: 11752687 [TBL] [Abstract][Full Text] [Related]
22. Role of steroid 5 alpha-reductase activity in sexual differentiation of the guinea pig. Connolly PB; Resko JA Neuroendocrinology; 1989 Mar; 49(3):324-30. PubMed ID: 2716956 [TBL] [Abstract][Full Text] [Related]
23. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate. Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433 [TBL] [Abstract][Full Text] [Related]
24. FCE 28260, a new 5 alpha-reductase inhibitor: in vitro and in vivo effects. Giudici D; Briatico G; Cominato C; Zaccheo T; Iehlè C; Nesi M; Panzeri A; di Salle E J Steroid Biochem Mol Biol; 1996 Jun; 58(3):299-305. PubMed ID: 8836165 [TBL] [Abstract][Full Text] [Related]
25. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. Imperato-McGinley J; Shackleton C; Orlic S; Stoner E J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740 [TBL] [Abstract][Full Text] [Related]
26. Ontogeny of cytosolic androgen receptors in the brain of the fetal rhesus monkey. Handa RJ; Connolly PB; Resko JA Endocrinology; 1988 May; 122(5):1890-6. PubMed ID: 3359967 [TBL] [Abstract][Full Text] [Related]
28. 5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review. Imperato-McGinley J Eur Urol; 1991; 20 Suppl 1():78-81. PubMed ID: 1722167 [TBL] [Abstract][Full Text] [Related]
29. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478 [TBL] [Abstract][Full Text] [Related]
30. The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase. Imperato-McGinley J; Binienda Z; Arthur A; Mininberg DT; Vaughan ED; Quimby FW Endocrinology; 1985 Feb; 116(2):807-12. PubMed ID: 3967629 [TBL] [Abstract][Full Text] [Related]
31. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract. George FW Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585 [TBL] [Abstract][Full Text] [Related]
32. The abnormal development of male sex organs in the rat using a pure antiandrogen and a 5 alpha-reductase inhibitor during gestation. Hib J; Ponzio R Acta Physiol Pharmacol Ther Latinoam; 1995; 45(1):27-33. PubMed ID: 8580516 [TBL] [Abstract][Full Text] [Related]
33. Maternal exposure to procymidone has no effects on fetal external genitalia development in male rabbit fetuses in a modified developmental toxicity study. Inawaka K; Kishimoto N; Higuchi H; Kawamura S J Toxicol Sci; 2010 Jun; 35(3):299-307. PubMed ID: 20519838 [TBL] [Abstract][Full Text] [Related]
34. Embryotoxicity of Norlestrin, a combined synthetic oral contraceptive, in rhesus macaques (Macaca mulatta). Prahalada S; Hendrickx AG Teratology; 1983 Apr; 27(2):215-22. PubMed ID: 6867943 [TBL] [Abstract][Full Text] [Related]
35. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen. Geller J J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat. Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729 [TBL] [Abstract][Full Text] [Related]
37. A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride. Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO Clin Pharmacol Ther; 1998 Dec; 64(6):636-47. PubMed ID: 9871428 [TBL] [Abstract][Full Text] [Related]
38. Changes in fetal plasma corticotropin-releasing hormone during androstenedione-induced labor in the rhesus monkey: lack of an effect on the fetal hypothalamo-pituitary-adrenal axis. Giussani DA; Winter JA; Jenkins SL; Tame JD; Abrams LM; Ding XY; Nathanielsz PW Endocrinology; 1998 Jun; 139(6):2803-10. PubMed ID: 9607787 [TBL] [Abstract][Full Text] [Related]
39. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs. Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194 [TBL] [Abstract][Full Text] [Related]
40. Age-related changes in brain and pituitary 5 alpha-reductase with finasteride (Proscar) treatment. Lephart ED Neurobiol Aging; 1995; 16(4):647-50. PubMed ID: 8544916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]